$75M Funding Will Help TreeFrog Develop Stem Cell Therapies

$75M Funding Will Help TreeFrog Develop Stem Cell Therapies

306479

$75M Funding Will Help TreeFrog Develop Stem Cell Therapies

TreeFrog Therapeutics has raised $75 million in financing to support the clinical development of its stem cell-derived cell therapies for Parkinson’s disease, the company said in a press release. The new financing round, which brings the total funding to date to $83 million, will allow the company to use its C-Stem technology to expand the growth of clinical-grade human-induced pluripotent stem cells (hiPSC)-derived cell therapies for Parkinson’s and other diseases. The French biotech startup expects to…

You must be logged in to read/download the full post.